Learn about upcoming meetings relevant to HIV malignancies and recent news about NCI HIV/AIDS and HIV malignancy research.
Events
NONE
News
NCI researchers identify the cell types that are infected with KSHV and the immune interactions in Kaposi sarcoma (KS) lesions using spatial transcriptomics with seven KS skin tumors.
Spatial Transcriptomics of Patients With Kaposi Sarcoma Identifies Mechanisms of Immune Evasion
December 2025
Investigators supported in United States and Argentina have published the first study to integrate transcriptomic profiles of various cohorts of KS.
Integrative functional genomics analysis of Kaposi sarcoma cohorts
October 2025
NCI researchers and the Immunotherapy Trials Network 12 demonstrated the safety of pembrolizumab HIV-associated Kaposi sarcoma (KS). Pembrolizumab use also resulted in a high rate of durable responses HIV-associated KS.
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma
October 2024
OHAM supported investigators recently published a study that provides the highest resolution mapping of antigenicity across the entire KSHV proteome.
February 2024